The safety of early applications of synthetic biology may be adequately addressed by the existing regulatory framework for biotechnology, but further advances in this emerging field are likely to create significant challenges for U.S. government oversight, according to a new report.
The Synthetic Biology Project is being launched to identify gaps in our knowledge of the potential risks of the field, explore public perceptions towards it, and examine governance options that will both ensure public safety and facilitate innovation. Take the quiz! Winners Announced!
Synthetic biology is being touted by scientists and venture capitalists as “the next big thing.” Researchers claim to be on the brink of creating artificial life in a laboratory and making the world’s first synthetic microbes. But will the promises and pitfalls of synthetic biology catch governments, ethicists, experts, and the public by surprise?
Tracking the last five years of media coverage
A groundbreaking poll has found that nearly nine in 10 Americans say they have heard just a little or nothing at all about the emerging field of synthetic biology. This new insight into limited public awareness of emerging technologies comes on the cusp of a major leadership change in the nation’s capital.
Nanotechnology and synthetic biology are two of the most exciting fields in science. They are the focus of venture capitalists, government and university laboratories, major corporations, and startup companies. But how much have Americans heard about these two fields that promise to change virtually every aspect of their lives?